188 related articles for article (PubMed ID: 36177005)
1. A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL).
Tanaka Y; Tanaka R; Imaizumi N; Mizuguchi M; Takahashi Y; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Masuzaki H; Fukushima T
Front Immunol; 2022; 13():921606. PubMed ID: 36177005
[TBL] [Abstract][Full Text] [Related]
2. Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.
Tanaka Y; Takahashi Y; Tanaka R; Kodama A; Fujii H; Hasegawa A; Kannagi M; Ansari AA; Saito M
AIDS Res Hum Retroviruses; 2014 Jun; 30(6):542-52. PubMed ID: 24524420
[TBL] [Abstract][Full Text] [Related]
3. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
4. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with adult T-cell leukemia.
Uno H; Kawano K; Matsuoka H; Tsuda K
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):730-9. PubMed ID: 2618548
[TBL] [Abstract][Full Text] [Related]
5. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
6. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma.
Nakashima M; Tanaka Y; Okamura H; Kato T; Imaizumi Y; Nagai K; Miyazaki Y; Murota H
Cells; 2024 Jan; 13(2):. PubMed ID: 38247820
[TBL] [Abstract][Full Text] [Related]
7. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
8. Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia.
Sagara Y; Inoue Y; Ohshima K; Kojima E; Utsunomiya A; Tsujimura M; Shiraki H; Kashiwagi S
Cancer Sci; 2007 Feb; 98(2):240-5. PubMed ID: 17297657
[TBL] [Abstract][Full Text] [Related]
9. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
[TBL] [Abstract][Full Text] [Related]
10. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
11. Evaluating mRNA expression of tax, B chain of PDGF and PDGF-β receptors as well as HTLV-I proviral load in ATL patients and healthy carriers.
Atabati H; Esmaeili SA; Allahyari A; Shirdel A; Rahimi H; Rezaee SA; Momtazi-Borojeni AA; Rafatpanah H
J Med Virol; 2021 Jun; 93(6):3865-3870. PubMed ID: 32918495
[TBL] [Abstract][Full Text] [Related]
12. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
[TBL] [Abstract][Full Text] [Related]
13. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
14. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
Cheminant M; Lhermitte L; Bruneau J; Sicard H; Bonnafous C; Touzart A; Bourbon E; Ortonne N; Genestier L; Gaulard P; Palmic P; Suarez F; Frenzel L; Naveau L; Bazarbachi A; Dussiot M; Waast L; Avettand-Fenoel V; Brouzes C; Pique C; Lepelletier Y; Asnafi V; Marçais A; Hermine O
Blood; 2022 Sep; 140(13):1522-1532. PubMed ID: 35687761
[TBL] [Abstract][Full Text] [Related]
15. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
16. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
17. The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.
Saito M; Tanaka R; Fujii H; Kodama A; Takahashi Y; Matsuzaki T; Takashima H; Tanaka Y
Retrovirology; 2014 Aug; 11():74. PubMed ID: 25163482
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
Komatsu F; Tamiya H
Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
Hadlock KG; Rowe J; Perkins S; Bradshaw P; Song GY; Cheng C; Yang J; Gascon R; Halmos J; Rehman SM; McGrath MS; Foung SK
J Virol; 1997 Aug; 71(8):5828-40. PubMed ID: 9223472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
